Skip to main content

Table 5 Characteristic and therapeutic effect of patients receiving intravenous PMB among centers

From: Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study

 

Value for:

P

Sub-centers (n = 83)

Main center (n = 17)

Mechanical ventilation, n (%)

44 (53.01)

7 (41.18)

0.432

Septic shock, n (%)

40 (48.19)

9 (52.94)

0.721

Adverse events, n (%)

14 (16.87)

2 (11.76)

0.601

Non-survivors, n (%)

33 (39.75)

7 (41.18)

0.222

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us